Delivery Order SPE2DB24D1205-SPE2DB25FDATV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,270.22 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector medication. The award, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, was made under firm fixed-price terms with no set-aside designation. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $1,201.32 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pharmaceutical product, with an ultimate completion date of August 28, 2025. This non-set-aside, competitively awarded contract reflects firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger prime contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $6,289.44 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for REPATHA 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, competitively awarded delivery order with a completion date of September 26, 2025. The contract is performed at the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its primary operations as a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a $4,540.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 16, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of REPATHA 140 mg/ml SureClick auto-injector pharmaceutical product. This $3,920.72 firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,254.40 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 mg/ml SureClick auto-injectors. The contract, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a firm fixed price delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters and serves as a...
- The Defense Logistics Agency awarded a $5,164.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injector pharmaceutical product, with a completion date of October 16, 2025. This is a non-set-aside competitive award issued to the prime contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen Drug Corp's larger indefinite delivery contract vehicle with DLA...
- The Defense Logistics Agency awarded a $2,278.32 firm fixed price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 17, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $10,617.27 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with a completion date of June 11, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $30,136.70 by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, with an ultimate completion date of August 27, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDATVDelivery Order
The Defense Logistics Agency awarded a $31,184.84 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick (a medication auto-injector) on September 22, 2025, with an ultimate completion date of September 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The parent IDC contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order for REPATHA, a cardiovascular medication, reflects the company's extensive portfolio of brand-name and generic pharmaceuticals supporting Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.2k | 9/22/25 |